Heart Drug, Digitek, Recalled by Icelandic Drug Maker, Actavis
A drug known as Digitek administered to patients with heart problems, has been recalled by drug manufacturer, Actavis. The crux of the drug recall is that the medication itself is said to be double the thickness and strength of the normal dosage. It is believed that the consumption of this medication may lead to complications, including arrhythmia, decreased blood pressure and death.
The generic version, Digoxin, can cause a heightened risk of toxicity in patients who have or continue to experience renal failure. The proper amount of the Digoxin, notwithstanding the defective nature of the drug, is supposed to help strengthen a weak heart and suppress fluttering and erratic heartbeats. Some patients are alleging personal injuries related to the drug, including liver failure.
FDA warnings about the defective drug go back to 1999, so Actavis has got some explaining to do, especially as Digitek patients continue to claim personal injuries from the defective drug.
If you or a loved one has been injured or killed by this or any other defective drug, I would invite you to visit my website, www.samlevine.com or contact my office, Sam Levine, Attorney at Law.
